Lahore: Shareholders of Descon Oxychem Limited convened on October 20, 2026, at the company’s registered office to deliberate on significant agenda items during the 22nd Annual General Meeting. The meeting, adhering to Regulation No. 5.6.9 (b) of the Pakistan Stock Exchange (PSX) Rule Book, saw the ratification of crucial resolutions.

The meeting commenced at 10:00 AM, addressing the first agenda item which involved the confirmation of the minutes from the last Extraordinary General Meeting held on February 24, 2026. The Company Secretary had previously circulated the draft minutes among the members and shareholders. It was resolved that these minutes were confirmed and adopted, further authorizing the Chairman of the Meeting to sign them as a token of approval on behalf of the participants.

The second agenda item focused on the financial health of the company. The shareholders were presented with the audited financial statements for the year ending June 30, 2026. This included the Auditor’s and Directors’ reports, along with the Annual Audited Consolidated Financial Statements. Approval and adoption of these documents were crucial for the company’s transparency and accountability, which were unanimously resolved during the meeting.

According to information available from the Pakistan Stock Exchange (PSX), the resolutions passed during this AGM are pivotal for Descon Oxychem Limited as they align with the company’s strategic objectives and regulatory requirements, ensuring sustained corporate governance and financial integrity.

The resolutions passed are expected to reinforce the company’s operational framework and support its market positioning within the designated market category, underscoring Descon Oxychem Limited's commitment to maintaining robust corporate practices.